Last 12 months
Inside the activity.
0 purchase rows · 65 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 21 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 500 | $345.27 | $172,637.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,904 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $344.86 to $345.51, inclusive. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 359 | $344.03 | $123,506.34 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,404 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $343.79 to $344.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:54 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000217 · wf-form4_163701685702090.xml · derivative · entry 13 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:54 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 734 | $347.36 | $254,959.16 |
DisclosureSEC source: 0001713683-21-000217 · wf-form4_163701685702090.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,252 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $347.05 to $347.74, inclusive. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:54 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,292 | $346.43 | $794,018.94 |
DisclosureSEC source: 0001713683-21-000217 · wf-form4_163701685702090.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,986 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $345.99 to $346.89, inclusive. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:54 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,200 | $345.35 | $414,422.04 |
DisclosureSEC source: 0001713683-21-000217 · wf-form4_163701685702090.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,278 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $344.91 to $345.84, inclusive. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:54 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 900 | $344.19 | $309,772.98 |
DisclosureSEC source: 0001713683-21-000217 · wf-form4_163701685702090.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,478 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $343.87 to $344.61, inclusive. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:54 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,874 | $343.36 | $643,464.70 |
DisclosureSEC source: 0001713683-21-000217 · wf-form4_163701685702090.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,378 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.86 to $343.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:54 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000217 · wf-form4_163701685702090.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · derivative · entry 11 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 500 | $351.33 | $175,664.00 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 9 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $350.94 to $351.66, inclusive. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 497 | $350.20 | $174,048.16 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,263 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $349.89 to $350.71, inclusive. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 403 | $348.36 | $140,387.59 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,760 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $348.15 to $348.71, inclusive. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 200 | $347.24 | $69,448.00 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.10 to $347.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $345.67 | $34,567.00 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,363 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $344.64 | $34,464.00 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,463 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $343.49 | $34,349.00 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,563 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $340.94 | $34,094.00 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,663 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 01:19 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000215 · wf-form4_163650713386102.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · derivative · entry 15 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,784 | $316.30 | $564,276.70 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · nonDerivative · entry 8 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,252 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $316.06 to $316.73, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,700 | $315.58 | $852,057.90 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,036 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $315.02 to $315.99, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,000 | $314.37 | $314,369.00 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,736 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $313.95 to $314.75, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 500 | $313.21 | $156,604.00 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,736 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $312.92 to $313.51, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 400 | $312.17 | $124,866.00 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,236 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $311.72 to $312.47, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 316 | $311.01 | $98,280.04 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,636 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $310.66 to $311.45, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $309.29 | $92,787.00 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,952 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.02 to $309.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 20:34 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000213 · wf-form4_163553962520690.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · derivative · entry 10 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 395 | $313.24 | $123,731.02 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · nonDerivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $312.89 to $313.72, inclusive. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 749 | $312.55 | $234,096.58 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · nonDerivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,158 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $311.89 to $312.88, inclusive. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 436 | $311.23 | $135,696.41 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,907 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $310.83 to $311.73, inclusive. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 60 | $309.78 | $18,586.80 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,343 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $309.46 to $310.24, inclusive. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 160 | $308.46 | $49,354.00 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,403 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $308.01 to $308.99, inclusive. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 120 | $307.53 | $36,903.12 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,563 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $306.97 to $307.86, inclusive. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 80 | $306.00 | $24,480.20 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,683 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.60 to $306.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 20:13 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000211 · wf-form4_163536557786858.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2021 Filed Oct 19, 2021 21:02 UTC |
Schlossman RobertChief Legal Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001713683-21-000209 · wf-form4_163467735717997.xml · derivative · entry 4 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2023-01-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| October 18, 2021 Filed Oct 19, 2021 21:02 UTC |
Schlossman RobertChief Legal Officer
|
SaleCommon Stock | 4,000 | $300.01 | $1,200,032.00 |
DisclosureSEC source: 0001713683-21-000209 · wf-form4_163467735717997.xml · nonDerivative · entry 2 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,512 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300 to $300.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| October 18, 2021 Filed Oct 19, 2021 21:02 UTC |
Schlossman RobertChief Legal Officer
|
Exercise / conversionCommon Stock | 4,000 | $4.40 | $17,600.00 |
DisclosureSEC source: 0001713683-21-000209 · wf-form4_163467735717997.xml · nonDerivative · entry 1 Schlossman Robert · CIK 0001435941 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 20:10 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000207 · wf-form4_163432860582767.xml · derivative · entry 12 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 20:10 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,793 | $293.43 | $819,551.95 |
DisclosureSEC source: 0001713683-21-000207 · wf-form4_163432860582767.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,252 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $293.08 to $293.88, inclusive. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 20:10 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,500 | $292.76 | $731,910.00 |
DisclosureSEC source: 0001713683-21-000207 · wf-form4_163432860582767.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,045 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $292.08 to $293.07, inclusive. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 20:10 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,200 | $291.36 | $349,628.04 |
DisclosureSEC source: 0001713683-21-000207 · wf-form4_163432860582767.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,545 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $291.03 to $291.91, inclusive. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 20:10 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 507 | $290.25 | $147,154.98 |
DisclosureSEC source: 0001713683-21-000207 · wf-form4_163432860582767.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,745 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $290.00 to $290.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 20:10 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000207 · wf-form4_163432860582767.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 20:08 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000205 · wf-form4_163406928246716.xml · derivative · entry 11 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 20:08 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 240 | $270.40 | $64,895.45 |
DisclosureSEC source: 0001713683-21-000205 · wf-form4_163406928246716.xml · nonDerivative · entry 9 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F9 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $270.13 to $270.77, inclusive. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 20:08 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 360 | $269.55 | $97,038.61 |
DisclosureSEC source: 0001713683-21-000205 · wf-form4_163406928246716.xml · nonDerivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,003 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $269.06 to $270.01, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.